Mayo Clinic study reveals new drugs to treat hepatitis C in post-liver transplant patients

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic's campus in Florida, talks about his latest study — how two new oral medications, used post-liver transplant, are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up to one year.


December 2, 2014

Created by

Mayo Clinic